Schizotypal Personality in Healthy Adults Is Related to Blunted Cortisol Responses to the Combined Dexamethasone/Corticotropin-Releasing Hormone Test

被引:11
|
作者
Hori, Hiroaki [1 ,2 ]
Teraishi, Toshiya [1 ]
Ozeki, Yuji [1 ]
Hattori, Kotaro [1 ]
Sasayama, Daimei [1 ]
Matsuo, Junko [1 ]
Kawamoto, Yumiko [1 ]
Kinoshita, Yukiko [1 ]
Higuchi, Teruhiko
Kunugi, Hiroshi [1 ,2 ]
机构
[1] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1878502, Japan
[2] Japan Sci & Technol Agcy, CREST, Saitama, Japan
基金
日本学术振兴会;
关键词
Cortisol; Dexamethasone/corticotropin-releasing hormone test Hypothalamic-pituitary-adrenal axis; Schizotypal personality; PITUITARY-ADRENAL AXIS; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; DEXAMETHASONE-SUPPRESSION TEST; NEAR-INFRARED SPECTROSCOPY; COMBINED DEX/CRH TEST; VERBAL FLUENCY TASK; SCHIZOPHRENIC-PATIENTS; CHARACTER INVENTORY; MAJOR DEPRESSION; CRH TEST;
D O I
10.1159/000322146
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background/Aims: Schizotypy is viewed as a dimensional trait ranging from healthy people to schizophrenic spectrum patients. Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, and accumulated evidence suggests that schizophrenia is associated with altered HPA axis function; however, HPA axis function in relation to schizotypal personality has not been well documented. Methods: We examined the relationship between schizotypal traits as assessed with the Schizotypal Personality Questionnaire (SPQ) and cortisol responses to the combined dexamethasone/corticotropin-releasing hormone test in 141 healthy volunteers. Subjects were divided into three groups based on their cortisol responses to the dexamethasone/corticotropin-releasing hormone test: incomplete suppressors, moderate suppressors, and enhanced suppressors. SPQ scores were compared between these three groups using the analysis of covariance, controlling for age and sex. Results: The analysis of covariance showed significant main effects of the suppressor status on the ideas of reference and suspiciousness/paranoid ideation subscales and cognitive-perceptual factor. Post-hoc analyses with Bonferroni correction revealed that the enhanced suppressors scored significantly higher than the moderate suppressors on these SPQ indices. Conclusion: These results indicate that nonclinical schizotypal traits in healthy adults are associated with blunted cortisol reactivity, potentially suggesting a shared neuroendocrinological mechanism across schizophrenia spectrum pathology. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:232 / 241
页数:10
相关论文
共 50 条
  • [41] The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
    Reimondo, Giuseppe
    Bovio, Silvia
    Allasino, Barbara
    De Francia, Silvia
    Zaggia, Barbara
    Micossi, Ilaria
    Termine, Angela
    De Martino, Francesca
    Paccotti, Piero
    Di Carlo, Francesco
    Angeli, Alberto
    Terzolo, Massimo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 159 (05) : 569 - 576
  • [42] Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls .1.
    Schmider, J
    Lammers, CH
    Gotthardt, U
    Dettling, M
    Holsboer, F
    Heuser, IJE
    BIOLOGICAL PSYCHIATRY, 1995, 38 (12) : 797 - 802
  • [43] A pilot study of a combined dexamethasone/corticotropin-(releasing) hormone test in patients with PTSD
    Muhtz, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 288 - 288
  • [44] Combined dexamethasone suppression-corticotropin releasing hormone stimulation test in medication free depressed patients and healthy volunteers
    Sher, Leo
    Cooper, Thomas B.
    Mann, J. John
    Oquendo, Maria A.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 112S - 112S
  • [45] Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone-corticotropin-releasing hormone test
    Ströhle, A
    Kellner, M
    Holsboer, F
    Wiedemann, K
    BIOLOGICAL PSYCHIATRY, 1998, 43 (05) : 371 - 375
  • [46] HUMAN PITUITARY CORTICOTROPH ADENOMAS INVITRO - MORPHOLOGIC AND FUNCTIONAL-RESPONSES TO CORTICOTROPIN-RELEASING HORMONE AND CORTISOL
    HORVATH, SE
    ASA, SL
    KOVACS, K
    ADAMS, LA
    SINGER, W
    SMYTH, HS
    NEUROENDOCRINOLOGY, 1990, 51 (03) : 241 - 248
  • [47] COMBINED CORTICOTROPIN-RELEASING HORMONE - VASOPRESSIN TEST - A NEW TEST FOR THE EVALUATION OF THE PITUITARY-ADRENAL SYSTEM
    SPATHSCHWALBE, E
    FEHM, HL
    BORN, J
    PFEIFFER, EF
    HORMONE AND METABOLIC RESEARCH, 1987, 19 (12) : 665 - 666
  • [48] Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression)
    Appelhof, BC
    Huyser, J
    Verweij, M
    Brouwer, JP
    van Dyck, R
    Fliers, E
    Hoogendijk, WJG
    Tijssen, JGP
    Wiersinga, WM
    Schene, AH
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 696 - 701
  • [49] OVINE CORTICOTROPIN-RELEASING HORMONE STIMULATION TEST IN PATIENTS WITH CHRONIC RENAL-FAILURE - PHARMACOKINETIC PROPERTIES, AND PLASMA ADRENOCORTICOTROPIC HORMONE AND SERUM CORTISOL RESPONSES
    SIAMOPOULOS, KC
    ELEFTHERIADES, EG
    PAPPAS, M
    SFEROPOULOS, G
    TSOLAS, O
    HORMONE RESEARCH, 1988, 30 (01) : 17 - 21
  • [50] Hormonal response to a combined dexamethasone/corticotropin-releasing hormone (DEX/CRH) test at remission predicts long-term outcome in depression
    Zobel, A
    Yassouridis, A
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 126 - 126